Abstract
We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this article, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from 4 clinics in 3 additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empirical management guidelines for treatment of gonococcal infection in Kenya.
Publication types
-
Multicenter Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Drug Resistance, Bacterial*
-
Female
-
Fluoroquinolones / administration & dosage*
-
Fluoroquinolones / pharmacology
-
Gonorrhea / drug therapy*
-
Gonorrhea / prevention & control
-
Gonorrhea / transmission
-
Humans
-
Kenya / epidemiology
-
Male
-
Mass Screening
-
Microbial Sensitivity Tests
-
Neisseria gonorrhoeae / drug effects
-
Neisseria gonorrhoeae / isolation & purification*
-
Prevalence
-
Sentinel Surveillance